logo

For the Inventor, By the Inventor

New York, NY, United States of America

Hynek Wichterle

This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignee: Columbia University. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hynek Wichterle. Retrieved from https://idiyas.com/inventor/hynek-wichterle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 16.7

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:

goldMedal6 out of 2,554 
 
Columbia University
 patents

Years Active: 2008-2025

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12227500 - Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress (2025-02-18),
2. 9765297 - Stem cell-based culture system for drug development (2017-09-19),
3. 9733237 - Methods for identifying candidates for the treatment of neurodegenerative diseases (2017-08-15),
4. 8969081 - Caudal motor neuron derived from embryonic stem cells under conditions essentially free of any retinoid (2015-03-03),
5. 7632679 - Systems and methods for screening for modulators of neural differentiation (2009-12-15),
6. 7390659 - Methods for inducing differentiation of embryonic stem cells and uses thereof (2008-06-24),

Title: Hynek Wichterle: Innovator in Neurodegenerative Disease Research

Introduction

Hynek Wichterle is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of neurodegenerative disease research. With a total of 6 patents, Wichterle has made strides in developing innovative solutions for treating various disorders.

Latest Patents

Wichterle's latest patents include groundbreaking inventions such as "Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress." This invention provides compounds that can be used in compositions containing a pharmaceutically acceptable carrier. It also outlines methods for treating or ameliorating the effects of disorders related to endoplasmic reticulum stress and neurodegenerative diseases. Another notable patent is the "Stem cell-based culture system for drug development," which focuses on culture systems comprising differentiated stem cells. This invention is aimed at identifying agents useful in treating degenerative nervous system disorders and is suitable for high-throughput screening applications.

Career Highlights

Wichterle is affiliated with Columbia University, where he continues to advance research in his field. His work has garnered attention for its potential impact on understanding and treating neurodegenerative diseases.

Collaborations

Throughout his career, Wichterle has collaborated with esteemed colleagues such as Thomas M Jessell and Ivo Lieberam. These collaborations have further enriched his research and contributed to the development of innovative solutions in the medical field.

Conclusion

Hynek Wichterle's contributions to neurodegenerative disease research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in treatment options for various disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…